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ABSTRACT 
Data derived  from a  correlated  morphological and  biochemical study suggest the 
following: (a) estradiol-17~,  diethylstilbestrol,  the estrogen antagonists nafoxidine 
(Upjohn  11,100),  and  Parke  Davis  CI628  induce  synthesis  of  an  endogenous 
peroxidase in the epithelium  of target tissues like the vagina, the cervix, the uterus, 
and  in  the  acinar  cells  of  the  estrogen-dependent  rat  mammary  tumor;  (b) 
peroxidase  is  a  "specific"  secretory  protein  of the  estrogen-sensitized  uterine 
endometrium;  (c)  peroxidase  synthesis  is  not  a  nonspecific  response  to  steroid 
hormone action, since progesterone and testosterone do not induce its synthesis; (d) 
endogenous  peroxidase  is  a  possible  diagnostic  protein  for  the  detection  of 
estrogen-dependent  growing  tissues,  including  breast  cancer;  (e)  movement  of 
exogenous horseradish  peroxidase  from  the  interstitium  to the  uterine  lumina  is 
restricted  by tight junctions  located  at the  apices of epithelial  cells.  Estrogen  and 
antagonists do not appear to influence the transepithelial  movement of exogenous 
peroxidase  into the lumen. 
The uterus, cervix, vagina, and mammary gland of 
mammals  require  estrogen  for their  postpubertal 
trophic  development  and  for the  maintenance  of 
their  differentiated  state.  Indeed,  the presence of 
estrogen-binding  proteins  (estrogen  receptors  or 
estrophiles,  Jensen et  al.,  1966 a) in these tissues 
and  of estrogen  dependency  of  rat  and  human 
mammary carcinoma are well documented (Hug- 
gins et al.,  1959; Jensen et al.,  1966 b; Jensen and 
DeSombre,  1972;  Jensen  et  al.,  1972;  Heuson et 
al.,  1972). 
In the course of our investigation it was discov- 
ered that tissues displaying growth dependency on 
estrogen  synthesize  and  secrete  "specific marker 
proteins" into their lumina. These results show (a) 
that  synthesis  of peroxidase ~ (or  a  hemoprotein 
with peroxidatic activity) is a consistent marker for 
estrogen-dependent  tissues (carcinogen-induced 
rat  mammary  carcinoma,  cervix,  vagina,  and 
uterus),  (b) estrogen  antagonists (Upjohn  11,100; 
~Throughout  this paper, the  DAB-positive  reaction 
product will be referred to as peroxidase, since uterine 
peroxidase is a well-documented enzyme (see text) and 
since the histochemical medium employed is designed to 
demonstrate peroxidase activity. It is of course possible 
that  what  is being visualized in either  a hemeprotein, 
which may possess peroxidase activity, or several sub- 
stances with peroxidasic activity. The biochemical char- 
acterization of this enzyme as a peroxidase is still very 
limited. 
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tradiol-17fl receptors,  and which have pronounced 
antiuterotrophic  and  growth-inhibitory effects on 
estrogen-dependent rat mammary carcinoma, also 
activate genes for the synthesis of peroxidase in the 
uterus,  cervix,  and  vagina,  and  (c)  the  cycle  of 
peroxidase  synthesis  and  secretion  in  the  cervix, 
vagina, and uterus coincides with the estrous cycle 
of mature  rats,  and  of that of immature  rats and 
mature  ovariectomized  rats  after  injection of es- 
tradiol- 17fl  and diethylstilbestrol. 
MATERIALS  AND  METHODS 
Preparation of the Mammary 
Tumor Specimens 
Mammary  carcinomas  were  induced  in  50-day  old 
female Sprague-Dawley rats by a single feeding of 20 mg 
of  7,12-dimethylbenz(a)anthracene  (DMBA)  in  2  ml 
sesame  oil  according  to  Huggins  et  al.  (1959).  In 
bilaterally  ovariectomized  animals,  estradiol-17  B  was 
given at  a  dose  of 2.5  ug  per day  for 6  days per wk. 
Biopsy samples of tumor were excised from ether-anes- 
thetized intact and ovariectomized rats, and from ovari- 
ectomized rats receiving estrogen. The tissue was imme- 
diately immersed in cold Formalin-glutaraldehyde fixa- 
tive (Karnovsky,  1965). After 30-45 rain, tissue samples 
were  rinsed  in  several  changes  of  0.1  M  cacodylate 
buffer, pH 7.2, for 8 h, and prepared for the demonstra- 
tion  of  endogenous  peroxidase  activity  by  techniques 
described below. 
Administration  of Estrogen Antagonists, 
Estrogen, and Other Steroids 
23-day old female rats were given subcutaneous injec- 
tions  of  varying  amounts  (30-500  p.g) of  nafoxidine 
(Upjohn  11,100,  Duncan  et  al.,  1963)  or  Parke-Davis 
C1628,  originally called CN 55,945-27  (Callantine et al., 
1966), in 0.1  ml glycerol. Some animals were also given 
injections of the antagonist 30 min before injections with 
estrogen.  In  other  experiments,  the  antagonists  were 
administered at 6-h intervals from the 23rd through the 
28th day of life. 
Diethylstilbestrol  (Sigma  Chemical  Co.,  St.  Louis, 
Mo.),  and  estradiol-17~  (Sigma)  at  concentrations of 
0.1-0.4 p.g dissolved in 0.1 ml glycerol were injected into 
23-day old rats.  Higher doses of estrogen (1.4-4 ~tg/0.1 
ml) dissolved in glycerol were also injected into immature 
females or mature castrates (I 10-150 g). 
Rats  either  were  given a  single dose  of antagonist, 
estrogen, or antagonist plus estrogen, or else were given 
injections at 6-h intervals. At least six rats were used at 
varying  time  periods  between  60  min  and  96  h  after 
hormone or antagonist injection. 
Progesterone and testosterone at doses of I-2 mg in 
0.1 ml glycerol were injected into immature rats in order 
to examine the effect of other steroid hormones. Control 
experiments  also  involved  the  injection of glycerol  or 
saline into immature and ovariectomized females. 
Studies  with Cycling Rats 
The  stage  of the  estrous  cycle  was judged  by light 
microscope  observations  of  vaginal  smears.  Animals 
were induced into a state of constant estrus by exposure 
to  prolonged  periods of light,  according to  procedures 
described by Lawton and Schwartz (1967). 
The uterine fluid from rats during the various phases 
of  the  estrous  cycle  and  during  constant  estrus  was 
collected via a syringe, the needle of which was inserted 
into the lumen of the uterus. The fluid was either used at 
once, or else stored at 0~  until needed. 
Demonstration  of Endogenous and 
Exogenous Peroxidase Activity 
Biopsy samples of mammary carcinoma and tissues 
from  cycling rats (uteri,  cervix, vagina, hypothalamus, 
anterior  pituitary,  ovaries)  were  excised  under  ether 
anesthesia  and  immersed  in  a  mixture  of  cold  4% 
glutaraldehyde-l%  formaldehyde  in  0.1  M  cacodylate 
buffer, pH 7.2 (Karnovsky,  1965). In other experiments 
these tissues were  excised  from ether-anesthetized rats 
that  had  been  perfused  for  30-45  rain  with  the  same 
fixative. The tissues were washed for 8 h  in cacodylate 
buffer, cut into 50-100-t~m thick sections and placed in 
Tris-HCI buffer at pH 7.2. The slices were then incubated 
for  30-45  rain  in  medium  composed  of  10  mg  3,3- 
diaminobenzidine-tetra HCI  in  10  ml  Tris-HCl  buffer 
(pH  7.0)  containing  0.3%  H202.  Some  sections  were 
incubated in medium lacking H202. 
For the demonstration of exogenous peroxidase activ- 
ity, 0. I ml of 0.9%  NaCI containing horseradish peroxi- 
dase (Sigma, Type  VI) at a  concentration of  l  mg/ml 
was  injected  via  the  saphenous  vein  into  immature 
females and into immature females receiving physiologi- 
cal doses of estrogen (estradiol- 17~, diethylstilbestrol), or 
antagonist for  periods  of 60  min  72 h.  Animals were 
sacrificed at various time intervals between 3 and 30 rain 
after injection of the tracer. The tissue was then fixed in 
situ in anesthetized rats, excised, and immersed for 45-60 
min  in  cold  fixative.  After  an  8-h  rinse  in  cacodylate 
buffer, 100-am thick slices of tissue were incubated in the 
DAB-H20~ medium described above. 
Microscope  Techniques 
The  aldehyde-fixed,  incubated,  and  postosmicated 
tissues  were  dehydrated  in  graded  ethanol-water solu- 
tions and embedded in Epon. Sections, either unstained 
or stained for 1 min with lead citrate, were examined in 
the Hitachi HU  I IC or Siemens Elmiskop  101 electron 
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graphed with an Olympus microscope. 
Analyses  of Rat Uterine Fluid 
Fluids were taken from uteri of cycling rats in estrus 
and constant estrus, and from immature females 72 h 
after administration of estradiol- 17/5 or diethylstilbestrol. 
In some experiments, fluid was passed through a Mil- 
lipore filter (Millipore Corp., Bedford, Mass.) (0.45 t.tm 
pore size), while in other experiments the natural fluid 
was used after centrifugation to remove cell debris. 
The protein content of the fluid was determined by the 
method of Lowry et al. (1951), with a Heath 700 series 
spectrophotometer. 
The  highly sensitive colorimetric  peroxidase assay 
technique using DAB as  hydrogen donor was  used to 
measure peroxidase activity in uterine fluids (Herzog and 
Fahimi, 1973). Horseradish peroxidase (Sigma Type VI) 
and lactoperoxidase dissolved in distilled water or in 0.05 
M phosphate buffer at concentrations of 0.05-0.5 #g/ml 
served as reference control samples. 
RESULTS 
Cytochemical Localization  of Endogenous 
Peroxidase Activity in DMBA-Induced Rat 
Mammary Carcinoma 
The growing estrogen-dependent rat mammary 
carcinoma  is  composed  of  well-formed  alveoli, 
ductules, and interalveolar fibrous connective tis- 
sue.  The  large  glandular cells  surround  a  wide 
lumen  that  contains  secretory  product  and 
sloughed  cell  processes.  The  cells  possess  basal 
nuclei and  a  well-developed secretory  apparatus 
consisting of supranuclear Golgi cisternae, granu- 
lar  endoplasmic reticulum,  and  apical  secretory 
vesicles. 
Intense endogenous peroxidase activity is pres- 
ent in the cisternae of the nuclear envelope, some 
parts of the Golgi complex, and in cisternae of the 
granular  endoplasmic  reticulum  of  the  growing 
hormone-dependent tumor (Figs.  l, 2). Numerous 
vesicles  and dilated cisternae of the endoplasmic 
reticulum in the  apical cytoplasm of acinar cells 
contain peroxidase-positive material. The material 
in  the  lumina of the  alveoli and  ductules stains 
intensely for peroxidase activity (Fig. 2, inset). Not 
all cells of the alveoli (of the hormone-dependent 
tumor) stained positively for endogenous peroxi- 
dase activity (Fig. l A), as moderately reactive and 
unreactive cells lined the acini. 
The  regressing  tumor  of  the  castrate  female 
contains flattened acinar cells and a poorly devel- 
oped  secretory  apparatus.  The  acinar  cells  are 
entirely negative for peroxidase activity (Fig. 3 A), 
as  are  the  cells of hormone-independent tumors 
which continue to grow after ovariectomy. In some 
glandular cells the peroxidase-positive material is 
present  in single vesicles  and  vacuoles  in acinar 
cells (Fig. 3) of the regressing tumor. Acinar cells 
of the growing tumor in castrates receiving injec- 
tions of estrogen stain intensely positive for endog- 
enous peroxidase activity (Fig. 4). 
Peroxidase Activity in the Cervical and 
Vaginal Epithelium  of the Estrogen- and 
Antagonist-Treated  Immature Rat, and in 
the Cycling Rat 
The  stratified  squamous epithelium of the  va- 
gina and cervix proliferate to form a  keratinized 
epithelium after stimulation with estradiol-17/3  or 
diethylstilbestrol, and after treatment with anties- 
trogens (CI628, Upjohn 11,100). Only the interme- 
diate and superficial layers of the vaginal epithe- 
lium  stain  positively  for  endogenous  peroxidase 
activity. The  reaction appears  12-72 h  after  the 
injection of  physiological doses  of estradiol-17B 
into  immature  rats  (Fig.  5,  5  A,  Table  I).  The 
peroxidase activity is present in the nuclear enve- 
lope, in the cisternae of the granular endoplasmic 
reticulum,  and  in  isolated  vesicles  in  the  cyto- 
plasm. The Golgi cisternae are weakly stained. The 
more flattened superficial cells contain large vacu- 
oles with peroxidase. Peroxidase-positive material 
also appeared to coat the extracellular surfaces of 
the superificial layers of the vaginal epithelium. 
Cervical and vaginal cells from animals treated 
with  CI628  or  Upjohn  ll,100  underwent  some 
proliferation and keratinization. By 72 h, however, 
the superficial cells were mucinogenic. Peroxidase 
staining was also less intense than after treatment 
with  estrogen,  but  its  localization in the  nuclear 
envelope and in cisternae of the granular endoplas- 
mic reticulum was prominent. 
Our results suggest that estrogens and antago- 
nists  stimulate  the  intermediate  and  superficial 
cells  of  the  vaginal  and  cervical  epithelium  to 
synthesize and secrete peroxidase. 
Uterine Peroxidase: Induction  by 
Estradiol-17~ Diethylstilbestrol, 
Antiestrogens,  and during the Estrous 
Cycle of the Rat 
The distribution of endogenous peroxidase  ac- 
tivity in the  epithelial and glandular cells of the 
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estradiol and  CI628  has  been  reported by Churg 
and Anderson (1974).  In closely correlated studies 
reported here, we show that the synthetic estrogen, 
diethylstilbestrol,  and  the  estrogen  antagonist, 
nafoxidine, also induce synthesis and secretion of 
peroxidase  in  the  uterine  epithelial  ceils  of  the 
immature  rat.  Peroxidase activity appears within 
12-24  h  after treatment  with estrogen and estro- 
gen-antagonists  (see  Table  I). The  nuclear enve- 
lope,  the  cisternae  of the  granular  endoplasmic 
reticulum, and some regions of the Golgi appara- 
tus  are  involved in  the  elaboration, storage,  and 
transport of the peroxidase (Figs. 6, 7). Peroxidase 
staining is intense in the epithelium of the estradi- 
ol-17B-treated animal, in the estrogen plus CI628- 
or nafoxidine-treated rat, and after diethylstilbes- 
trol (Fig. 6,  insets). The epithelium of the imma- 
ture uterus was devoid of peroxidase activity (Fig. 
6, inset no. 3). 
Not  all cells of the  uterine epithelium synthe- 
sized and stored peroxidase (Churg and Anderson, 
1974L Marked heterogeneity in peroxidase storage 
appeared after treatment with the synthetic agents 
C1628 (Fig. 8) and diethylstilbestroi (Fig. 9). In all 
cases, however, the normal and synthetic estrogen 
and the inhibitors to estrogen stimulated synthesis 
and  secretion of the peroxidase within 24 h  after 
injection  into  immature  rats.  Increment  in  cell 
mass  was  associated  with  stored  enzyme  in  the 
mucosal lining. Progesterone and testosterone in- 
jections did not stimulate peroxidase synthesis in 
immature  or ovariectomized rats  (Table  I),  sug- 
gesting that induced peroxidase is not a nonspecific 
response to the injection of steroid hormones. 
The  distribution  of peroxidase  in  the  uterine, 
vaginal, and cervical mucosa of the various stages 
of estrus in the rat was also examined (Table II). 
Our results show that endogenous peroxidase was 
only present in the epithelium of the uteri of rats 
during proestrus, estrus, and constant estrus. Sec- 
tions  from  the  hypothalamus  and  the  anterior 
pituitary consistently show no peroxidase reaction 
product under the conditions of this study. 
Analysis of the Uterine Fluids of the Rat 
By  use  of the  recently developed DAB colori- 
metric procedure for assaying peroxidase (Herzog 
and Fahimi, 1973), the relative kinetic activities of 
horseradish peroxidase, lactoperoxidase, and uter- 
ine fluid peroxidase were examined. It is clear that 
uterine  fluid peroxidase, under  the  conditions of 
our  experiments,  was  far  less  active  than  the 
purified peroxidases from plants and milk (Table 
Ill). Our data provide firm evidence, however, for 
a  uterine  fluid  peroxidase  in  rats  exposed  to 
estrogens. 
Effect of Estrogen and Inhibitors on the 
Movement of Horseradish  Peroxidase from 
the Interstitium to the Uterine Lumen 
The possibility exists that a blood-borne peroxi- 
dase could reach the uterine lumen via movement 
across junctions of the uterine mucosa. To test this 
possibility, horseradish peroxidase was injected for 
varying time  intervals into  the  blood  of animals 
treated  with  estradiol-17/5, diethylstilbestrol, and 
the  antiestrogens. The  uterine vasculature of im- 
mature and treated animals was readily permeable 
to passage of peroxidase; within 3 min the exoge- 
nous  peroxidase  filled  the  interstitium  between 
epithelial cells (Figs. 10  12).  At 72 h after injection 
of diethylstilbestrol into immature rats, intracellu- 
lar endogenous peroxidase and extracellular horse- 
radish  peroxidase  are  visualized  by  the  DAB 
procedure  (Fig.  9).  Extracellular  peroxidase 
reaches the apical junctional complexes, but does 
not  permeate  them.  At  earlier  periods after  es- 
tradiol-17B treatment  (6  12  h)  when  no endoge- 
nous peroxidase is visible in the cells, horseradish 
peroxidase  may  be  seen  within  the  extracellular 
space within 3-30 rain after its injection, blocked 
by  junctions  (Figs.  10-12).  Small  intracellular 
vesicles with  reaction product probably represent 
sites  of uptake  and  possible transport  of blood- 
borne  horseradish peroxidase through the epithe- 
lium  (Fig.  10). Exogenous  peroxidase  does  not 
permeate the junctions between gland cells of the 
uterus after treatment with estradiol-17B. 
Does  Uterine  Fluid Peroxidase Originate  in 
the Oviduct? 
To answer this question the oviducts of iaparo- 
tomized immature and ovariectomized mature rats 
were  ligated.  After  time  had  been  allowed  for 
healing  (3-14  days),  the  rats  were  subsequently 
injected with  physiological doses of estradiol-17~ 
and  examined  72  h  later  for  uterine  peroxidase 
activity. The epithelial cells and the uterine fluid 
contained  a  peroxidase that  therefore appears to 
originate in the uterus. 
DISCUSSION 
Estradiol-17B and  synthetic estrogen  (diethylstii- 
bestrol)  administered  to  ovariectomized animals 
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sensitive mammalian cells (Tata,  1966; Mueller et 
al.,  1958;  Williams-Ashman  and  Reddi,  1971). 
Not  only  do  they  maintain  general  metabolic 
processes, they also induce synthesis of "specific 
proteins" and structural differentiation in normal 
target cells (Kohler et al.,  1967;  O'Malley et al., 
1969;  Gorski  and  Notides,  1969;  Barnea  and 
Gorski,  1970;  DeAngelo and  Gorski,  1970),  and 
maintain  growth  and  proliferation  in  estrogen- 
dependent malignant tissues (Huggins et al., 1959). 
Specific protein synthesis precedes general protein 
synthesis (Hamilton, 1968),  increment in cytoplas- 
mic  mass,  and  cellular proliferation. Our  results 
show  that  tissues  requiring  estrogen  for  growth 
synthesize cell-specific marker proteins  that can be 
used  as  biochemical and  morphological markers 
for estrogen-induced differentiation. 
Mammary  Tumors 
The  DMBA-induced rat  mammary carcinoma, 
like  its  human  counterparts,  displays  estrogen- 
dependency  for  growth  (Dao,  1964;  Young  and 
Hallowes, 1973). Regression after ovariectomy can 
be  reversed  by  administration of estrogen  (Dao, 
1964)  and  after  hypophysectomy  by  doses  of 
prolactin  (Pearson  et  al.,  1972).  This  tumor  is 
known to contain estrogen receptors (Jensen et al., 
1967;  Kyser,  1970;  McGuire and Julian,  1971),  a 
characteristic  which  is  diagnostic  for  estrogen- 
dependent  human  mammary  carcinomas (Jensen 
et al., 1971). 
This  growing  hormone-dependent  tumor  dis- 
plays the identifying characteristic of endogenous 
peroxidase synthesis and  secretion.  After castra- 
tion, the tumor loses endogenous peroxidase activ- 
ity  which  is  correlated  with  diminution  of  the 
protein-synthetic apparatus in regressing cells de- 
scribed by others (Scott et  al.,  1967).  Moreover, 
since  peroxidase activity reappears  in  tumors  of 
castrates  given  estrogen  therapy,  and  is  absent 
from growing estrogen-independent tumors, it ap- 
pears that peroxidase is a  marker enzyme for the 
estrogen-dependent  DMBA  rat  mammary  carci- 
noma  (DeSombre  et  al.,  1975).  More  extensive 
studies are required to verify this suggestion. 
The Cervix and Vagina 
The  cervical and  vaginal epithelium undergoes 
changes  that  correspond  to  the  development  of 
secretory activity of the endometrium during the 
estrous cycle. Not only does estrogen stimulate an 
increase  in  the  number  of  the  cell  layers  with 
displacement  of  older  superficial  cells,  it  also 
induces  keratinization  of  the  intermediate  and 
superficial layers. From direct anatomical obser- 
vations  it  was  obvious  that  estradiol-178  and 
diethylstilbestrol induced  synthesis of peroxidase 
in  an  intermediate  layer  of squamous  cells that 
stored keratin filaments in their cytoplasm. Perox- 
idase appeared in these cells only during periods of 
endogenous estrogen stimulation (estrus and con- 
stant  estrus,  for  example)  or  after  injection  of 
hormone  to  spayed and  immature  rats,  and  was 
absent from castrates not receiving estrogen ther- 
apy. Nafoxidine and CI628 also stimulated peroxi- 
dase  synthesis  in  the  cervical and  vaginal cells. 
Peroxidase activity first appeared about 12 h after 
injection of estradiol-178, and was seen within the 
nuclear envelope, the granular endoplasmic reticu- 
lum,  and  in  cytoplasmic vesicles. The  material 
seemed to be secreted into the narrow extracellular 
space surrounding the intermediate and superficial 
cells. 
Uterus 
Antiestrogens like CI628 and nafoxidine usually 
have weak estrogenic (Duncan et al., 1963; Callan- 
tine et al.,  1966) and progestational activity (Em- 
mens and Martin,  1964). Nafoxidine administered 
for  6-12  wk  produced  in  most  rats  a  state  of 
permanent  diestrus  (Heuson  et  al.,  1972).  These 
inhibitors  administered  alone  or  with  estrogen 
induced hypertrophy of the uterine epithelial cells 
FIGURE  I  Diaminobenzidine-stained cells are shown in acini of the DMBA-induced rat mammary tumor 
of an intact rat (Fig.  I A, I-#m thick section). The peroxidase-positive activity is present in the nuclear 
envelope, in cisternae of the endoplasmic reticulum, and in small cytoplasmic vesicles (Fig.  1). Portions of 
the Golgi complex are weakly stained. Fig.  1, ￿  6,000. Fig. 1 A, ￿  150. 
FIGURE 2  Sections  through  the  acinar  lumen  of the  growing  breast  tumor  are  illustrated  in  these 
micrographs.  The lumen which contains homogeneously gray peroxidase-positive material (Fig. 2, 2 A) is 
lined by darkly stained ceils that contain peroxidase in their endoplasmic reticulum and in apical vesicles. 
Cytoplasmic processes from these cells are unstained (stars).  Fig. 2, ￿  7,000. Fig. 2 A, x  150. 
ANDERSON, KANG, AND  DESOMBRE  Peroxidases in Estrogen-Sensitive Tissues  673 FIGURE  3  Tissues from the regressing tumor in the castrate  rat  are entirely unreactive for endogenous 
peroxidase (Fig. 3 A, red cells; erythrocytes (rbc) are DA B-positive). Dilated cisternae (arrows) that contain 
peroxidase reaction product are present at the a0ices of some acinar cells. Fig. 3, ￿  16,000. Fig. 3 A, x  150. 
FIGURE  4  Acinar ceils of the  DMBA-induced rat  mammary tumor of a  castrate female that received 
daily estrogenic injections are  shown here.  Intense peroxidase  activity is present in  the cisternae of the 
endoplasmic reticulum. Ct, connective tissue. ￿  10,500. 
674 FIGURE  5  Sections through the vaginal epithelium of an  immature  rat  that received three injections of 
estradiol-17#  (0.4  ~g  per  injection)  over  a  72-h  period  are  shown  here.  In  the  semithick  toluidine 
blue-stained section (l-tim  thick),  closed circles  illustrate  the intermediate layer of epithelium in  which 
peroxidase staining first appears (Fig. 5 A). Vaginal endogenous peroxidase activity is seen in the nuclear 
envelope, in cisternae of the endoplasmic reticulum, and in cytoplasmic vesicles. Some peroxidase-positive 
material is also present on the surface of the cells in the superficial layers of the epithelium (stars). ￿  8,500. 
x  400. TABLE  1 
Distribution of Peroxidase Activity in Estrogen Target Tissues of Immature Female Rats after Injection 
Tissues 
Diethylstilbestrol or Estradiol- 17B*  Upjohn 11,100 CI628:~  Estradiol- I7B Plus CI628  Other Steroids 
imm  E6  E~4  E,0  E,~  E,e-t,  I~,  l,a  1~2  l,o  Ela~ El~a  Ei,~  Elur  PgandT 12-96h 
Ovary 
Oviduct 
Uterus  +  ++  +++  ++++  +  ++  +++  ++  +  ++  +++ 
Cervix  +  ++  ++  ++  +  ++  +++  ++  +  ++  ++ 
Vagina  +  ++  ++  ++  +  ++  +++  §  +  ++  ++ 
Hypothalamus 
Pituitary 
++++ 
++ 
++ 
m 
* E = 0.1-0.4/~g/24  h (physiological), or *E =  1-4/~g or 24 h (hyperphysiological). 
~/I~o,, = 50 #g/24 h or tl,~,  = 500 t~g/24 h. 
C1628 30 rain Estradiol-17#. 
Progesterone (Pg) (I rag/24 h~, Testosterone (T) (1 mg/24 h). 
TABLE  II 
Distribution oJ Peroxidase Activity in Mature Female Rats 
Tissues Binding 
Estrogen  Proestrus  Estras  Diestros  Lactating  Constant estrus  Ovex  Ovex + E2* 
Uterus  +  ++++  --  --  +++++  --  ++++ 
Cervix  +  +++  --  --  +++++  --  ++++ 
Vagina  +  +++  --  --  +++  --  +++ 
Breast  --  --  --  +  --  --  -- 
Hypothalamus  ....... 
Pituitary  ....... 
*  Dosage of estradiol-17B  =  0.4 ~g/24 h. 
TABLE  I11 
Specific Acitvity of Hemoproteins and Uterine Peroxidase* 
Hemoprotein 
Horseradish Peroxidase 
(Sigma VI) 
Lactoperoxidase (Sigma) 
Uterine Fluid 
E72~ 
Late r 
Constant r 
U/mg/min  U/ml/rain 
pH 5.0  pH 7.02  pH 7.02 
25.91 ￿  103 ~ 2.4SE  5.97 ￿  10  s •  0.16SE 
0.91 X 10' ~ 0.006 SE  0.769 ￿  108 •  0.035 SE 
U  / mg protein~rain 
2.36 •  719  ￿  10  -~ 
7.93 + 0.519 SE  813￿  10 -3 
11.33 -, 0.326 SE  777x  10  -s 
* Colorimetric assay using 3,Y-diaminobenzidine tetrahydrochloride as hydrogen donor according to Herzog and Fahimi, (1973). 
~: Fluid derived from immature rats receiving three injections of 0.4 t~g estradiol-17B over a 72-h period. 
and  the  accumulation of secretory material in the 
cells apices and  in well-developed glands (Heuson 
et  al.,  1972).  These investigators also attest to the 
weak  progestational  effects  of  nafoxidine.  Our 
findings  concur  that  nafoxidine  and  also  CI628 
stimulate secretory activity of the uterine mucosa; 
significant  amounts  of  the  material  stored  and 
secreted consist of peroxidase. Our enzyme kinetic 
studies on the uterine fluid verify the existence of a 
secreted  peroxidase in the uterus. 
Possible Functions of Hormone- 
Induced Peroxidases 
Thyroid  peroxidase  is  found  in  glands  under 
stimulation  by  TSH  derived  from  the  anterior 
pituitary:  atrophic glands lack  peroxidase (Strum 
and  Karnovsky,  1970).  Thyroid  peroxidase effec- 
tively  catalyzes  the  iodination  of  a  variety  of 
proteins (Coval  and Taureg,  1967).  Since  it cata- 
lyzes the  iodination  of tyrosyl residues in  thyrox- 
676  THE  JOURNAL OF  CELL BIOLOGY ￿9  VOLUME  64,  1975 FIGURES  6  AND  7  The insets are photographs of 100-/zm thick vibratome sections through the uterus of 
rats given three injections of 0.4/zg estradiol- 178 in 72 h (E72), three injections of estradiol- 17/~ (0.4 ~ag) and 
three  injections of CI628  (500  tzg)  over  a  72-h  period (E+I  72), and  of an  immature  rat  given  three 
injections  of 0.1  ml  glycerol  over  a  72-h  period  (Ira).  The  mucosa  of the  estrogen-  and  estrogen  + 
inhibitor-treated  rats  are  intensely stained  for peroxidase activity. The electron micrograph  shows the 
distribution  of endogenous  peroxidase  in  the  cisternae  of the  endoplasmic  reticulum  (ER),  in  apical 
secretory granules  (Sg),  and  vesicles, and  in  regions  of the  Golgi  complex  of endometrial cells  in  an 
estrogen-treated rat (Fig. 6), and in a C1628-treated rat (Fig. 7). Fig. 6,  x  5,000. Fig. 7, ￿  9,000.  Insets, x 
15. FIGURE  8  In rats given three injections of C1628  (500/~g per injection) over 72 h, the heterogeneity of 
peroxidase staining in the uterine epithelium is apparent. Some cells are intensely reactive, while adjacent 
cells are devoid of peroxidase activity (stars).  x  6,500. 
FIGURE  9  This heterogeneity of peroxidase staining is also apparent in the uterine mucosa of a rat given 
three injections of diethylstilbestrol (0.4/~g per injection) in 72 h; the stars show cells weakly reactive for 
endogenous peroxidase. The extracellular space shows DAB-positive staining for horseradish peroxidase 3 
min after injection of the tracer into the blood via the saphenous vein.  x  6,400. FIGURES  10-12  3 min after the injection of horseradish peroxidase into immature rats treated for 6 h with 
0.1/~g estradiol-17B, DAB-positive material (hrp) appears in the extracellular space surrounding epithelial 
cells of the uterine mucosa and in the apical cisternae (er). These cells possess few pinocytotic vesicles (v). 
Fig.  10,  x  11,500.  Fig.  I1,  x  17,000.  Fig.  12,  x  6,000. ine,  its  activity  is  essential to  thyroid  hormone 
production. Peroxidase in the endometrium could 
be  involved in  iodination of proteins or in other 
halogenation  reactions  similar to  that  described 
for the thyroid system. 
Other functions have been ascribed to the perox- 
idases of the estrogen-stimulated uterus. Indeed, it 
is  well established that  peroxidases can  catalyze 
the  oxidation  of various  phenolic hormones,  in- 
cluding  estrogen,  to  phenoxy  radicals  that  may 
secondarily bind proteins (Williams-Ashman and 
Johnson,  1960;  Wiiliams-Ashman  and  Reddi, 
1971).  Peroxidase  in  the  presence  of  hydrogen 
peroxide can catalyze the conjugation of estradiol 
to proteins and some thiols (Klebanoff and Segal, 
1960;  Klebanoff,  1965;  Jellinck and  Irwin,  1963; 
Jellinck and Fletcher, 1970) as well as to DNA and 
other  polynucleotides  (Jellinck  and  Fletcher, 
1970).  Brtikelmann and  Fawcett (1969)  and  BrS- 
kelmann  (1969)  indicated  that  the  amount  of 
tritiated estradiol bound to uterine tissue could be 
enhanced by the addition of hydrogen peroxide to 
the  DAB  incubation  medium;  the  radioactivity 
appeared  over  sites  of tissue  peroxidase.  Subse- 
quent studies by Lyttle and Jellinck (1972) suggest 
that peroxidase can metabolize estrogen to water- 
soluble by-products. Lyttle and Jellinck (1972) and 
BriSkelmann and Fawcett (1969) suggest that uter- 
ine peroxidase may therefore function to terminate 
estrogen  action  in  target  tissues.  This  is  quite 
conceivable,  but  entirely  unproven  to  date.  The 
question  remains  open:  are the  estrogen-induced 
peroxidases  of  the  female  reproductive  system 
catalysts for estrogen metabolism; are they halo- 
genation agents; or do they have other physiologi- 
cal roles? 
It is well known that lactoperoxidase and myelo- 
peroxidase in association with halides and hydro- 
gen  peroxide  exert  bactericidal,  viruscidal  and 
fungicidal effects  (Klebanoff and  Luebke,  1965; 
Klebanoff et  al.,  1966;  Belding et al.,  1970)  and 
possibly a  spermicidal function  (Smith  and  Kle- 
banoff,  1970;  Klebanoff and  Smith,  1970).  We 
cannot rule out the possibility that rat mammary 
carcinoma,  vaginal,  cervical, and  uterine peroxi- 
dases are functioning as germicidal agents. 
What appears clear is that endogenous peroxi- 
dase or one or more hemoproteins with peroxidase 
activity  are  produced  in  tissues  dependent  on 
estrogen for growth, and that they are secreted into 
the tissue lumina. Competitive growth antagonists 
to estrogen also induce peroxidase synthesis in the 
epithelial cells of these tissues. These observations 
and the partial agonist effects of such antiestrogens 
suggest  that  these  agents  may  at  least  partially 
participate in receptor-mediated gene activation of 
such tissues. Preliminary indirect evidence showing 
some  nuclear  estrogen  receptor  in  uteri  after 
treatment with nafoxidine in vivo (Rochefort et al., 
1972)  or  in  vitro  (Clark  et  al.,  1973)  would  be 
consistent  with  this  concept.  Studies  with  such 
antiestrogens to discern the  induction of specific 
proteins  as  well  as  general  trophic  responses 
should lead to a better understanding of the role of 
hormones and their antagonists in gene-regulated 
responses of normal or neoplastic tissues. 
The  Transendometrial  Transport 
of Enzymes 
Analyses of uterine fluids show the existence of 
prealbumin,  albumin,  and  globulins  similar  to 
those  present  in  the  blood  plasma  (Beier,  1968; 
Peterson  and  Spaziani,  1971).  Our studies, using 
an  exogenous  protein tracer ~horseradish peroxi- 
dase), show that the movement of plasma-derived 
proteins into the uterine lumen is blocked by tight 
junctions between endometrial cells. Some tracer 
is incorporated by pinocytosis in the endometrium. 
A  series of intracellular vesicles aggregate at the 
cell  apices,  giving  the  suggestion  that  material 
could be transported to the lumen by an intracellu- 
lar route. 
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